Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2550.0000 (-12.07%) ($2550.0000 - $2550.0000) on Wed. Jan. 26, 2005. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 4.96% (three month average) | | RSI | 28 | | Latest Price | $2550.0000(-12.07%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CAPR declines -2.4% a day on average for past five trading days. | | Weekly Trend | CAPR declines -4.2% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
GLD(1%) LQD(1%) SHY(1%) TIP(1%) TLT(1%) | | Factors Impacting CAPR price | CAPR will decline at least -2.48% in a week (0% probabilities).
EWI(-3%) QQQ(-2%) EWP(-2%) EWJ(-2%) EWG(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -2.48% (StdDev 4.96%) | | Hourly BBV | 0 () | | Intraday Trend | 0% | | | | | |
|
| Resistance Level | $2939.64 | | 5 Day Moving Average | $2830(-9.89%) | | 10 Day Moving Average | $2730.77(-6.62%) | | 20 Day Moving Average | $2939.64(-13.25%) | | To recent high | -21.5% | | To recent low | 0% | | Market Cap | $50.229b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |